Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 15;194(4):1602-8.
doi: 10.4049/jimmunol.1402632. Epub 2015 Jan 12.

Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation

Affiliations

Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation

Sheng Xiao et al. J Immunol. .

Abstract

T cell Ig and mucin domain (Tim)-1 identifies IL-10-producing regulatory B cells (Bregs). Mice on the C57BL/6 background harboring a loss-of-function Tim-1 mutant showed progressive loss of IL-10 production in B cells and with age developed severe multiorgan tissue inflammation. We demonstrate that Tim-1 expression and signaling in Bregs are required for optimal production of IL-10. B cells with Tim-1 defects have impaired IL-10 production but increased proinflammatory cytokine production, including IL-1 and IL-6. Tim-1-deficient B cells promote Th1 and Th17 responses but inhibit the generation of regulatory T cells (Foxp3(+) and IL-10-producing type 1 regulatory T cells) and enhance the severity of experimental autoimmune encephalomyelitis. Mechanistically, Tim-1 on Bregs is required for apoptotic cell (AC) binding to Bregs and for AC-induced IL-10 production in Bregs. Treatment with ACs reduces the severity of experimental autoimmune encephalomyelitis in hosts with wild-type but not Tim-1-deficient Bregs. Collectively, these findings suggest that in addition to serving as a marker for identifying IL-10-producing Bregs, Tim-1 is also critical for maintaining self-tolerance by regulating IL-10 production in Bregs.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Tim-1Δmucin mice at 16-18+ months of age develop splenomegaly and multi-organ inflammation
A) Representative images of organs from 16-18+-month old WT and Tim-1Δmucin mice. B&C) Representative flow cytometry plots showing CD4+ T cell phenotypes in spleens (B) and livers (C) isolated from 16-18+-month old WT and Tim-1Δmucin mice (n = 10). D) Representative histopathology of livers and lungs from 16-18+-month-old WT and Tim-1Δmucin mice. There are massive mononuclear cell infiltrates in the Tim-1Δmucin mice. Hematoxylin and eosin stain, 15x.
Figure 2
Figure 2. Tim-1 and BCR or IL-21 signaling together strongly promoted B cell IL-10 production while a defect in Tim-1 signaling in B cells reduced IL-10 production
Purified splenic CD19+ B cells from 2-3 month-old WT, Tim-1Δmucin or Tim-1−/− mice were cultured in the presence of anti-Tim-1 (clone 5F12), (Fab’)2 fragment anti-IgM or both without (A) or with IL-21 (B). After 3 days, IL-10 production in culture supernatants was measured by ELISA. * P < 0.01; ns, not significant. C) Representative flow cytometry plots showing Tim-1 expression by splenic CD19+ B cells from WT and Tim-1−/− mice after 3-day culture in the presence of IL-21. n ≥ 3 per group.
Figure 3
Figure 3. Tim-1 expression or defects affects the balance between regulatory and inflammatory cytokines in B cells that subsequently alter T cell responses
A) Purified splenic CD19+ B cells from WT or Tim-1−/− mice were cultured in the presence of anti-IgM ((Fab’)2 fragment) for 24 h. Total RNA was isolated, and relative expression (mean ± SEM; n = 5) of Tim-1, IL10, IL12, IL6, and IL1b mRNA was measured by realtime PCR. * P < 0.01. B) WT total CD4+ T cells (10 x 106/mouse) were co-transferred together with WT or Tim-1Δmucin CD19+ B cells (20 x 106) into Rag1−/− mice. One day after, mice were immunized with MOG35-55/CFA to induce EAE. At the peak of disease, splenic Tim-1+ and Tim-1 CD19+ B cells were purified from WT and Tim-1Δmucin groups of mice. Total RNA was isolated, and relative expression (mean + SEM; n = 5) of Tim-1, IL10, IL12, IL6, and IL1b mRNA was measured by realtime PCR. * P < 0.01. C) WT naïve CD4+ T cells were cultured with splenic CD19+ B cells purified from WT or Tim-1−/− IL-10GFP/+ mice in the presence of anti-CD3 under Th0 (no cytokine), Th1 (IL-12 + anti-IL-4), Th2 (IL-4 + anti-IL-12/anti-IFN-γ), Th17 (TGF-β1 + IL-6), Tr1 (TGF-β1 + IL-27), and iTreg (TGF-β1) conditions. After culture for 4 days, production of indicated cytokines in T cells and IL-10 (GFP+) in B cells was measured by flow cytometry after intracellular cytokine staining. Representative of 5 independent experiments was shown. D) WT CD4+ naïve T cells were cultured with Tim-1+ or Tim-1 B cells purified from WT in the presence of anti-CD3 under Th17, Tr1, and iTreg conditions. After culture for 4 days, production of indicated cytokines in T cells was measured by flow cytometry after intracellular cytokine staining. Representative data from 3 independent experiments are shown.
Figure 4
Figure 4. Effect of Tim-1 expression or defects in B cells on EAE and T cell responses
A) WT total CD4+ T cells (10 × 106/mouse) were co-transferred together with either WT or Tim-1−/− CD19+ B cells (20 × 106) into Rag1−/− mice; the recipients were then immunized with MOG35-55/CFA to induce EAE. Mice were scored daily for clinical signs of EAE (left panel; n =10 per group). * P < 0.05. On day 20, CNS-infiltrating mononuclear cells were isolated and examined for the frequencies of IFN-γ+, IL-17+, and Foxp3+ cells in CD4+ T cell gates by flow cytometry after intracellular staining (middle panel; n = 5). CNS-infiltrating CD4+ T cells were also isolated and measured for their IL10 mRNA expression by realtime PCR (right panel; ** P < 0.01; n = 4 per group). B) WT total CD4+ T cells (10 × 106) were co-transferred together with WT (20 × 106), Tim-1-−/− (20 × 106), or Tim-1−/− (20 × 106) plus WT Tim-1+ (2 × 106) B cells into Rag1−/− mice; the recipients were then immunized with MOG35-55/CFA to induce EAE. Mice (n = 8-10 per group) were scored daily for clinical signs of EAE. * P < 0.05.
Figure 5
Figure 5. Effect of apoptotic cells on WT and Tim-1−/− B cells and the development of EAE
A) WT, Tim-1Δmucin and Tim-1−/− B cells from 2-4 month-old mice were incubated with CMFDA-labeled apoptotic WT thymocytes (AC) for 30 min, and analyzed by flow cytometry. WT and Tim-1Δmucin B cells had comparable Tim-1 expression. Gating strategy for Tim-1 staining is shown in the left panel. n = 3-5 per group. B) WT and Tim-1−/− B cells were cultured with unlabeled AC for 3 days, and IL-10 production in culture supernatants was then measured by ELISA. * P < 0.001; ns, not significant; n = 5. C) WT total CD4+ T cells (10 × 106/mouse) were co-transferred together with either WT or Tim-1−/− CD19+ B cells (20 × 106) into Rag1−/− mice. Apoptotic WT thymocytes (30 × 106/mouse) were injected one day before immunization with MOG35-55/CFA for EAE induction. Mice (n = 8 per group) were scored daily for clinical signs of EAE. * P < 0.05.

Similar articles

Cited by

References

    1. DiLillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci. 2010;1183:38–57. - PubMed
    1. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012;30:221–241. - PubMed
    1. Mann MK, Ray A, Basu S, Karp CL, Dittel BN. Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis. Autoimmunity. 2012;45:388–399. - PMC - PubMed
    1. Yang M, Rui K, Wang S, Lu L. Regulatory B cells in autoimmune diseases. Cell Mol Immunol. 2013;10:122–132. - PMC - PubMed
    1. Balkwill F, Montfort A, Capasso M. B regulatory cells in cancer. Trends Immunol. 2013;34:169–173. - PubMed

Publication types

MeSH terms